Improved solubility and pharmacokinetics of PEGylated liposomal honokiol and human plasma protein binding ability of honokiol
Authors:
- Xian-Huo WangXWXian-Huo Wang
- Lu-Lu CaiLCLu-Lu Cai
- Xiao-Yan ZhangXZXiao-Yan Zhang
- Lin-Yu DengLDLin-Yu Deng
- Hao ZhengHZHao Zheng
- Chong-Yang DengCDChong-Yang Deng
- Jiao-Lin WenJWJiao-Lin Wen
- Xia ZhaoXZXia Zhao
- Yu-Quan WeiYWYu-Quan Wei
- Li-Juan ChenLCLi-Juan Chen
- 1 May 2011
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 410 (1-2) , 169-174
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer modelsPhytotherapy Research, 2008
- Liposomal honokiol, a potent anti-angiogenesis agent, in combination with radiotherapy produces a synergistic antitumor efficacy without increasing toxicityExperimental & Molecular Medicine, 2008
- Antimicrobial and Cytotoxic Activities of Neolignans from Magnolia officinalisChemistry & Biodiversity, 2004
- Honokiol, a Small Molecular Weight Natural Product, Inhibits Angiogenesis in Vitro and Tumor Growth in VivoJournal of Biological Chemistry, 2003
- Antiperoxidative Activity of Neolignans from Magnolia obovataJournal of Pharmacy and Pharmacology, 1997
- Which polymers can make nanoparticulate drug carriers long-circulating?Advanced Drug Delivery Reviews, 1995
- The determination of liposome captured volumeChemistry and Physics of Lipids, 1993
- Methods of Determining Plasma and Tissue Binding of DrugsClinical Pharmacokinetics, 1992
- Pharmacological Properties of Magnolol and Hōnokiol Extracted fromMagnolia officinalis: Central Depressant EffectsPlanta Medica, 1983
- Plasma and Tissue Binding Considerations in Drug DispositionDrug Metabolism Reviews, 1983